BridgeMD
New treatment option for Stroke With Hemiparesis
Official title Home-based Graded Repetitive Arm Supplementary Program for Quality of Life and Functional Upper Limb Recovery
ClinicalTrials.gov ID: NCT07146789
What this study is testing
- What it's testing
- In post-stroke rehabilitation of the affected upper limb, increasing treatment intensity has been shown to lead to better outcomes compared to conventional approaches with fewer hours of therapy per day and week. However, logistical, human, and material constraints in neurorehabilitation centres often limit the feasibility of increasing treatment intensity.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Be of legal age.
- Have suffered only one stroke and be clinically stable.
- At least 3 months must have passed since the stroke and less than 12 months.
- Signing of informed consent
- Be able to communicate any adverse effects (e.g. shoulder pain)
You likely can't join if
- Having neurological conditions other than stroke.
- Experiencing excessive pain in the affected upper limb that prevents the patient from correctly performing the exercises proposed in the programme...
- Having a visual perception deficit that prevents the patient from correctly performing the exercises proposed in the programme.
- Excessive muscle tone (spasticity or hypertonia) that prevents the person from correctly performing the exercises proposed in the programme. Asworth...
- A Folstein Mini-Mental State Examination (MMSE) score of ≥22 is required.
See the full eligibility criteria
- Be of legal age.
- Have suffered only one stroke and be clinically stable.
- At least 3 months must have passed since the stroke and less than 12 months.
- Signing of informed consent
- Be able to communicate any adverse effects (e.g. shoulder pain)
- Be able to follow instructions and perform the exercises independently for one hour. If they are not able to do so, have the help of a caregiver to ensure that the exercises are performed.
- Perform at least 10º of active wrist or finger extension.
- Ability to raise the scapula of the affected upper limb against gravity.
- Having neurological conditions other than stroke.
- Experiencing excessive pain in the affected upper limb that prevents the patient from correctly performing the exercises proposed in the programme. Visual Analogue Scale (VAS \> 7).
- Having a visual perception deficit that prevents the patient from correctly performing the exercises proposed in the programme.
- Excessive muscle tone (spasticity or hypertonia) that prevents the person from correctly performing the exercises proposed in the programme. Asworth \> 2.
- A Folstein Mini-Mental State Examination (MMSE) score of ≥22 is required.
The study team makes the final eligibility decision.
Where it's taking place
- Valencia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valencia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.